ACVH Achieve Life Sciences Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ACVH Achieve Life Sciences prior to the earnings report this week,
I would consider purchasing the 5usd strike price Calls with
an expiration date of 2024-6-21,
for a premium of approximately $0.65.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
ACHV trade ideas
ACHV Biotech ACHV had good earnings in mid-March and has been in an ascending triangle since that time.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline as notified by
an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest
compared with the average upside of the analysts of $ 22+ ( see the link below)
I will take out a sizeable stock position and also some insurance in the form of a long term
put option to manage the risk on the trade.
ACHV preparing to Reverse SHORTACHC previously ran up in a high tight flag pattern in my previous idea.
It has been slowly ascending in a narrowing channel. ( ascending wedge)
There has been a little push in volume on the indicator as price has
approached the upper boundaries of the channel. The average
directional index has decreased into the " chop zone" where consolidation
and lack of direction describes the price action.
I see this an an opportunity for a short entry. I will watch things on
the 1 and 5 minute charts for the best entry possible and the
ride this volatile biotechnology stock a long as possible.
Top 6 Trading Patterns:Have You Seen This Trading Method Before?The problem with candle stick patterns is that it takes time
to master them
--
Also, you need some interest level to really get it
--
Notice this pattern?
There are about 4 indicators on this chart
--
You need to master Japanese candle stick patterns
--
The Top 6 indicators used in this chart:
1-EMA 13 Days
2-Stochastic
3-RSI
4-MACD
5-MACD histogram
6-Japanese Candle Stick Patterns
--
Before you trade the inverse pattern
which is a very professional strategy
--
YOu need to master these indicators mentioned above
--
After you master them you will learn how to
--
Trade the market and screen for good patterns to trade
--Notice how the price is below the market value in this pattern
--
Thank you for the boost this chart example is my thank you gift to you
--
Study these patterns and indicators
when you do come back to this chart
--
so that you see this history to confirm your
professional knowledge
--
Study more
--
Regards,
Lubosi Forex
ACHV a Biotech company after earningsACHV on the 4H seems to be demonstrating a "High Bull Flag Pattern"
after a big uptrend to start the year. Earnings on Thursday 3/16 were
quite favorable.On the relative volume indicator Friday, May 17th
showed a paradoxical huge selling volume spike to finish out this week.
( I mislabelled this as upcoming on the chart)
Paradoxically, the last earnings report in November was poor but
resulted in strong upward price action.
The MACD histogram is at the zero line.
Will ACHV resume the uptrend after earnings? Was the selling volume
an institutional trader fake out to set up a lower price to buy call options?
According to Tip Ranks, the analysts give ACHV a high rating with significant
upside. See the link below Who knows but this may be worth watching for signs of
buying volume and accumulation to fuel bullish momentum.
ACHV | Time to Start Loading | LongAchieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Achieve Life Sciences Inc 🧙Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Achieve Life Sciences Inc 🧙Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ACHV Trending Down in STFor this back-testing example, zoom in/out to review the full analysis. Enjoy every sandwich ;) EES
Expecting price action to move to the 72.8% retrace level of the last point on a Bullish Cypher Pattern.
The 72.8% hits directly on the trend line and am expecting a strong upward push - DO YOUR OWN RESEARCH on this pattern!
If you saw my earlier post, as of recent it posted a 100% gain. Am expecting another 100% move in the longer-term after this Cypher pattern completes at point D.
Transparency: As I had my $ in other stocks, i did not realize any gains on this stock.
ACHV Brekout Stock AlertACHV has been trading within a Sideways Channel since Sept. 4th and is currently on the lower end of the channel. The stock has the potential to retest the $10 Levels of Resistance, and if it does, then we're expecting a $11.60-$13.48 wouldn't be impossible to see with this stock. ACHV began it's Late-Stage Trials of Cytisinicline for Smoking Cessation on 10/07/20 and has not yet released those results, so a catalyst could be coming here soon. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Follow for more trade alerts and information & egister your account for Instant Alerts by clicking the link in our signature.
Achieve Life Sciences, Inc. Reversal targets Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Short interest 22%
ACHV Achieve Life Sciences 10X potential! Highest undervalued!On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K.
With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is how much upside potential does it have.
On July 31 ACHIEVE ANNOUNCES PATENT GRANTED IN THE U.S. FOR NOVEL ANALOGS OF CYTISINICLINE FOR USE IN CNS AND ADDICTION INDICATIONS.
Also Short Interest in Achieve Life Sciences Inc Drops By 81.1%.
Achieve Life Sciences issued its quarterly earnings results on Aug 4th. The biopharmaceutical company reported ($1.68) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.80) by $2.12, Fidelity Earnings reports.
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
Would you buy this? ACHV Look at the volume!On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders.
Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock.
Achieve Life Sciences is scheduled to be releasing its earnings data after the market closes on Thursday, August 6th. Analysts expect Achieve Life Sciences to post earnings of ($0.19) per share for the quarter.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.